Roivant Sciences
Price & Volume
Stats
See more52W Range | $10.70-$32.79 |
Market Cap | $21.4B |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $8.2M |
Revenue Growth (YoY) | -66.7% |
Gross Profit (12 Mos) | -$673.9M |
Diluted EPS | -$0.54 |
News
See moreYahoo Finance • 8 days ago
Roivant anticipates $950M Moderna payment in July as it outlines 2H 2026 mosliciguat and IMVT-1402 readouts
Yahoo Finance • 8 days ago
Roivant (ROIV) Q4 2025 Earnings Transcript
Yahoo Finance • 8 days ago
Can a New Arthritis Drug Make Immunovant the Next Biotech Star?
Yahoo Finance • 8 days ago
These Two Biotech Stocks Rocketed — And One Just Broke Out
About
CEO | Mr. Matthew Gline |
Address | 50 Broadway, London, United Kingdom, SW1H 0DB |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 721 |